Atria Investments Inc Increases Stock Position in Danaher Corporation $DHR

Atria Investments Inc increased its position in shares of Danaher Corporation (NYSE:DHR) by 21.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 39,951 shares of the conglomerate’s stock after buying an additional 7,088 shares during the period. Atria Investments Inc’s holdings in Danaher were worth $7,921,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. WFA of San Diego LLC bought a new stake in shares of Danaher in the 2nd quarter worth about $26,000. Howard Hughes Medical Institute acquired a new position in Danaher in the second quarter worth about $27,000. TruNorth Capital Management LLC bought a new stake in Danaher in the third quarter valued at about $28,000. Tripletail Wealth Management LLC acquired a new stake in Danaher during the third quarter valued at approximately $31,000. Finally, Heartwood Wealth Advisors LLC bought a new position in Danaher during the 3rd quarter worth approximately $37,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Danaher

In related news, Director Teri List sold 3,298 shares of the company’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the sale, the director directly owned 20,762 shares in the company, valued at approximately $4,702,593. This represents a 13.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 11.10% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research analysts have recently commented on DHR shares. KeyCorp reaffirmed an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. HSBC raised their target price on shares of Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a report on Monday, December 1st. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a report on Saturday, November 22nd. The Goldman Sachs Group cut their price target on Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a report on Thursday, January 29th. Finally, Wells Fargo & Company upped their price objective on Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a research note on Monday, December 15th. Twenty equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $253.86.

Danaher Stock Down 1.2%

NYSE DHR opened at $212.37 on Friday. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $242.80. The company has a market capitalization of $150.01 billion, a P/E ratio of 42.14, a PEG ratio of 2.90 and a beta of 0.91. The company’s 50 day simple moving average is $228.63 and its 200 day simple moving average is $215.46. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. The company had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.Danaher’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.14 earnings per share. Equities research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were paid a dividend of $0.32 per share. The ex-dividend date of this dividend was Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is 25.40%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.